< Return to News

WCC’s Dr. Schwartzberg, MD, on HR+ Breast Cancer: Treatment Trial Results

Friday, December 8, 2017

West’s very own Dr. Lee Schwartzberg participated in the 2017 San Antonio Breast Cancer Symposium video program yesterday! During his time at #SABCS17, he was interviewed about Phase II study findings evaluating exemastane with or without enzalutamide in patients with hormone receptor-positive breast cancer.

Click below to see the full video!